CLINICAL_TRIALS
trial_result
· 2021-02-08
Clinical Trial Update: Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease [Phase 2]
Summary
Phase 2 trial updating on gut microbiota modification for refractory Crohn's disease; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Pennsylvania | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-02-08